PMHS
Polomar Health Services, Inc.
Price Chart
Latest Quote
$0.09
+0.00 (+0.00%)
Current Price
| Previous Close | $0.09 |
| Open | $0.05 |
| Day High | $0.05 |
| Day Low | $0.05 |
| Volume | 1 |
Stock Information
| Shares Outstanding | 28.05M |
| Total Debt | $825K |
| Cash Equivalents | $88K |
| Revenue | $1.65M |
| Net Income | $-10.27M |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Market Cap | $2.63M |
| EPS (TTM) | $-0.37 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.37M |
| Sales | $1.65M |
| Income | $-10.27M |
| Book/sh | $-0.04 |
| Cash/sh | $0.00 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 0.15 |
| Current Ratio | 0.27 |
Returns & Margins
| ROA | -122.78% |
| ROE | -297.81% |
| Gross Margin | 61.08% |
| Operating Margin | -0.69% |
Ownership
| Insider Ownership | 64.49% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.60 |
| P/B | -2.13 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.10 |
| SMA50 | $0.17 |
| SMA200 | $0.25 |
| RSI | 100.00 |
| ATR | 0.0016 |
| Shares Float | 13.15M |
Performance History
| Week | +17.38% |
| Month | -68.70% |
| Quarter | +43.58% |
| 6 Months | +17.38% |
| YTD | -88.26% |
| Year | -80.34% |
| 3 Years | -97.36% |
| 5 Years | -99.97% |
| 10 Years | -95.30% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.09 | 0 |
| 2026-06-17 | $0.09 | 0 |
| 2026-06-16 | $0.09 | 0 |
| 2026-06-15 | $0.09 | 975 |
| 2026-06-12 | $0.08 | 0 |
| 2026-06-11 | $0.08 | 0 |
| 2026-06-10 | $0.08 | 0 |
| 2026-06-09 | $0.08 | 0 |
| 2026-06-08 | $0.08 | 0 |
| 2026-06-05 | $0.08 | 0 |
| 2026-06-04 | $0.08 | 0 |
| 2026-06-03 | $0.08 | 0 |
| 2026-06-02 | $0.08 | 0 |
| 2026-06-01 | $0.08 | 5,367 |
| 2026-05-29 | $0.07 | 30,000 |
| 2026-05-28 | $0.15 | 0 |
| 2026-05-27 | $0.15 | 0 |
| 2026-05-26 | $0.15 | 0 |
| 2026-05-22 | $0.15 | 500 |
| 2026-05-21 | $0.12 | 5,666 |
| 2026-05-20 | $0.15 | 9,975 |
| 2026-05-19 | $0.30 | 0 |
About Polomar Health Services, Inc.
Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on PMHS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $27,921 | $4,294 | $0 |
| Cost Of Revenue | $27,921 | $4,294 | $0 |
| Total Revenue | $58,824 | $41,844 | $34,526 |
| Operating Revenue | $58,824 | $41,844 | $34,526 |
| Expenses | |||
| Interest Expense | $41,837 | $495 | - |
| Total Expenses | $1,358,320 | $482,676 | $215,979 |
| Net Non Operating Interest Income Expense | $-41,837 | $-495 | $138 |
| Interest Expense Non Operating | $41,837 | $495 | - |
| Operating Expense | $1,330,399 | $478,382 | $215,979 |
| Selling And Marketing Expense | $45,998 | $27,932 | - |
| General And Administrative Expense | $1,284,401 | $450,450 | $215,979 |
| Other Income Expense | - | $-146,670 | $191 |
| Other Non Operating Income Expenses | - | $-146,617 | - |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-1,341,333 | $-587,997 | $-181,124 |
| Net Interest Income | $-41,837 | $-495 | $138 |
| Normalized Income | $-1,341,333 | $-587,944 | $-181,315 |
| Net Income From Continuing And Discontinued Operation | $-1,341,333 | $-587,997 | $-181,124 |
| Total Operating Income As Reported | $-1,299,496 | $-440,832 | $-181,453 |
| Net Income Common Stockholders | $-1,341,333 | $-587,997 | $-181,124 |
| Net Income | $-1,341,333 | $-587,997 | $-181,124 |
| Net Income Including Noncontrolling Interests | $-1,341,333 | $-587,997 | $-181,124 |
| Net Income Continuous Operations | $-1,341,333 | $-587,997 | $-181,124 |
| Pretax Income | $-1,341,333 | $-587,997 | $-181,124 |
| Operating Income | $-1,299,496 | $-440,832 | $-181,453 |
| Gross Profit | $30,903 | $37,550 | $34,526 |
| Interest Income | - | $0 | $138 |
| Interest Income Non Operating | - | $0 | $138 |
| Per Share | |||
| Diluted EPS | $-0.05 | $-0.02 | $-0.00 |
| Basic EPS | $-0.05 | $-0.02 | $-0.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,036,216 | $-581,616 | $-181,644 |
| Reconciled Depreciation | $263,280 | $5,833 | - |
| EBITDA (Bullshit earnings) | $-1,036,216 | $-581,669 | $-181,453 |
| EBIT | $-1,299,496 | $-587,502 | $-181,453 |
| Diluted Average Shares | $27,656,094 | $26,112,909 | $45,254,302 |
| Basic Average Shares | $27,656,094 | $26,112,909 | $45,254,302 |
| Diluted NI Availto Com Stockholders | $-1,341,333 | $-587,997 | $-181,124 |
| Selling General And Administration | $1,330,399 | $478,382 | $215,979 |
| Other Gand A | $1,284,401 | $450,450 | $215,979 |
| Total Unusual Items | - | $-53 | $191 |
| Total Unusual Items Excluding Goodwill | - | $-53 | $191 |
| Gain On Sale Of Security | - | $-53 | $191 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-1,136,244 | $-48,703 | $186,769 |
| Total Assets | $9,951,773 | $107,099 | $261,484 |
| Total Non Current Assets | $9,874,960 | $94,832 | $0 |
| Non Current Prepaid Assets | $9,000 | $9,000 | - |
| Goodwill And Other Intangible Assets | $9,735,375 | $4,167 | - |
| Other Intangible Assets | $9,735,375 | $4,167 | - |
| Current Assets | $76,813 | $12,267 | $261,484 |
| Inventory | $68,777 | $3,459 | - |
| Receivables | $1,845 | $0 | $30,000 |
| Accounts Receivable | $1,845 | $0 | $30,000 |
| Cash Cash Equivalents And Short Term Investments | $6,191 | $8,808 | $225,619 |
| Cash And Cash Equivalents | $6,191 | $8,808 | $225,619 |
| Cash Financial | $6,191 | $8,808 | $225,619 |
| Prepaid Assets | - | $0 | $5,865 |
| Debt | |||
| Net Debt | $1,132,379 | - | - |
| Total Debt | $1,187,751 | $81,664 | - |
| Long Term Debt And Capital Lease Obligation | $14,864 | $49,180 | - |
| Current Debt And Capital Lease Obligation | $1,172,887 | $32,484 | - |
| Current Debt | $1,138,570 | - | - |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $1,352,642 | $151,635 | $74,715 |
| Total Non Current Liabilities Net Minority Interest | $14,864 | $49,180 | $0 |
| Current Liabilities | $1,337,778 | $102,455 | $74,715 |
| Current Notes Payable | $1,138,570 | - | - |
| Payables And Accrued Expenses | $164,891 | $69,971 | $74,715 |
| Payables | $164,891 | $69,971 | $74,715 |
| Accounts Payable | $164,891 | $39,464 | $5,012 |
| Equity | |||
| Common Stock Equity | $8,599,131 | $-45,036 | $186,269 |
| Total Equity Gross Minority Interest | $8,599,131 | $-44,536 | $186,769 |
| Stockholders Equity | $8,599,131 | $-44,536 | $186,769 |
| Retained Earnings | $-2,911,163 | $-1,569,830 | $-981,833 |
| Preferred Stock Equity | - | $500 | $500 |
| Other Equity Interest | - | $140,500 | $37,044 |
| Other | |||
| Ordinary Shares Number | $27,657,679 | $10,913,804 | - |
| Share Issued | $27,657,679 | $10,913,804 | - |
| Tangible Book Value | $-1,136,244 | $-49,203 | $186,269 |
| Invested Capital | $9,737,701 | $-45,036 | $186,269 |
| Working Capital | $-1,260,965 | $-90,188 | $186,769 |
| Capital Lease Obligations | $49,181 | $81,664 | - |
| Total Capitalization | $8,599,131 | $-44,536 | $186,769 |
| Additional Paid In Capital | $11,482,636 | $1,275,156 | $1,023,476 |
| Capital Stock | $27,658 | $109,638 | $108,082 |
| Common Stock | $27,658 | $109,138 | $107,582 |
| Preferred Stock | $0 | $500 | $500 |
| Long Term Capital Lease Obligation | $14,864 | $49,180 | - |
| Current Capital Lease Obligation | $34,317 | $32,484 | - |
| Dueto Related Parties Current | $0 | $30,507 | $69,703 |
| Net PPE | $130,585 | $81,665 | - |
| Accumulated Depreciation | $-9,488 | $0 | - |
| Gross PPE | $140,073 | $81,665 | - |
| Leases | $49,435 | $0 | - |
| Other Properties | $90,638 | $81,665 | - |
| Properties | $0 | $0 | - |
| Treasury Shares Number | - | $0 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-1,110,680 | $-534,307 | $-40,934 |
| Operating Activities | |||
| Operating Cash Flow | $-1,019,787 | $-534,307 | $-40,934 |
| Cash Flow From Continuing Operating Activities | $-1,019,787 | $-534,307 | $-40,934 |
| Investing Activities | |||
| Capital Expenditure | $-90,893 | - | - |
| Investing Cash Flow | $-90,893 | $0 | - |
| Cash Flow From Continuing Investing Activities | $-90,893 | $0 | - |
| Financing Activities | |||
| Financing Cash Flow | $1,108,063 | $317,496 | $266,553 |
| Cash Flow From Continuing Financing Activities | $1,108,063 | $317,496 | $266,553 |
| Net Other Financing Charges | $-30,507 | $101,304 | - |
| Issuance Of Capital Stock | - | $216,192 | $229,544 |
| Net Common Stock Issuance | - | $216,192 | $229,544 |
| Common Stock Issuance | - | $216,192 | $229,544 |
| Other | |||
| Issuance Of Debt | $1,138,570 | $42,564 | $37,009 |
| Interest Paid Supplemental Data | $41,837 | $495 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 |
| End Cash Position | $6,191 | $8,808 | $225,619 |
| Beginning Cash Position | $8,808 | $225,619 | $0 |
| Changes In Cash | $-2,617 | $-216,811 | $225,619 |
| Net Issuance Payments Of Debt | $1,138,570 | $-69,703 | $37,009 |
| Net Short Term Debt Issuance | $1,138,570 | $-69,703 | $37,009 |
| Short Term Debt Issuance | $1,138,570 | $42,564 | $37,009 |
| Net PPE Purchase And Sale | $-90,893 | $0 | - |
| Purchase Of PPE | $-90,893 | $0 | - |
| Change In Working Capital | $58,266 | $47,857 | $-33,805 |
| Change In Payables And Accrued Expense | $125,429 | $34,452 | $2,060 |
| Change In Prepaid Assets | $0 | $-4,135 | $-5,865 |
| Change In Inventory | $-65,318 | $-3,460 | - |
| Change In Receivables | $-1,845 | $30,000 | $-30,000 |
| Changes In Account Receivables | $-1,845 | $30,000 | $-30,000 |
| Depreciation Amortization Depletion | $263,280 | $5,833 | - |
| Depreciation And Amortization | $263,280 | $5,833 | - |
| Net Income From Continuing Operations | $-1,341,333 | $-587,997 | $-181,124 |
| Repayment Of Debt | - | $-112,267 | $0 |
| Short Term Debt Payments | - | $-112,267 | $0 |
| Change In Other Working Capital | - | $-9,000 | - |
| Change In Payable | - | $8,771 | $2,060 |
| Change In Account Payable | - | $8,771 | $2,060 |
| Stock Based Compensation | - | $0 | $173,995 |
| Asset Impairment Charge | - | $20,000 | $0 |
Fetched: 2026-02-02